牋牋Since its inception, Laboratorios Rubi骽as specialised in providing unique and essential products to Spanish doctors and patients, beginning with an ion-exchange resin for the treatment of dialysis patients. This continued with the introduction of innovative therapies such as gold salts for the treatment of rheumatoid arthritis, colestyramine for hyperlipidaemia, bisphosphonates for Paget抯 disease and osteoporosis and methylphenidate for the treatment of attention-deficit hyperactivity disorder (ADHD), amongst others.

牋牋This specialisation has involved the company抯 active participation in a large number of congresses, symposia, meetings, courses and seminars, where new therapeutic developments could be presented to specialists and opinion-leaders.

牋牋Today, the company has over 50 medical representatives covering the whole of Spain. Rubi髍epresentatives visit all hospitals and specialist centres in Spain, keeping health professionals